Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$824,875
+$177,843 QoQ
Shares Held
3,278
+10.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#2,727
of 4,153 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Bancorp, Inc /ME/ holds $5,656,881 across 11 Drug Manufacturers - General names. ABBV ranks #2 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,272 | $2,100,838 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
3,278 | $824,875 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,509 | $707,906 | |
| 4 | PFE |
Pfizer Inc
|
20,600 | $496,047 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,257 | $418,147 | |
| 6 | LLY |
ELI LILLY & Co
|
290 | $347,834 | |
| 7 | AMGN |
Amgen Inc
|
720 | $260,726 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,700 | $214,778 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $824,875 | 3,278 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $647,032 | 2,975 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $692,324 | 3,030 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $748,336 | 3,232 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $560,014 | 3,017 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $468,905 | 2,238 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $397,336 | 2,236 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $442,354 | 2,240 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $374,598 | 2,184 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $397,705 | 2,184 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $339,849 | 2,193 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $320,926 | 2,153 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $276,600 | 2,053 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $344,717 | 2,163 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $297,362 | 1,840 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $255,804 | 1,906 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $294,986 | 1,926 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $397,331 | 2,451 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $346,623 | 2,560 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $269,027 | 2,494 | Shares | Sole | 2021-10-19 | |
| 2021-03-31 | $277,258 | 2,562 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||